Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers

Immunotherapy has become the standard-of-care in many solid tumors. Despite the significant recent achievements in the diagnosis and treatment of cancer, several issues related to patients’ selection for immunotherapy remain unsolved. Multiple lines of evidence suggest that, in this setting, the vis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagni, Fabio, Guerini-Rocco, Elena, Schultheis, Anne Maria, Grazia, Giulia, Rijavec, Erika, Ghidini, Michele, Lopez, Gianluca, Venetis, Konstantinos, Croci, Giorgio Alberto, Malapelle, Umberto, Fusco, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862285/
https://www.ncbi.nlm.nih.gov/pubmed/31683784
http://dx.doi.org/10.3390/ijms20215452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862285/
https://www.ncbi.nlm.nih.gov/pubmed/31683784
http://dx.doi.org/10.3390/ijms20215452

Ejemplares similares